Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer statistics.CA Cancer J Clin. 2022; 72: 7-33
- Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2019). National Cancer Institute, DCCPS.(Available at:)
- Extent of surgery for papillary thyroid carcinoma: the debate continues: comment on "surgery for papillary thyroid carcinoma.Arch Otolaryngol Head Neck Surg. 2010; 136: 1061-1063
- Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.CA Cancer J Clin. 2018; 68: 55-63
- Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.Thyroid. 2018; 28: 1301-1310
- Staging systems for papillary thyroid carcinoma: a review and comparison.Ann Surg Mar. 2007; 245: 366-378
- Impact of the change from the seventh to eighth edition of the AJCC TNM classification of malignant tumours and comparison with the MACIS prognostic scoring system in non-medullary thyroid cancer.BJS Open. 2019; 3: 623-628
- Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system.Surgery. 1987; 102: 1088-1095
- An expanded view of risk-group definition in differentiated thyroid carcinoma.Surgery. 1988; 104: 947-953
- Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.Surgery. 1993; 114 (; discussion 1057-8): 1050-1057
- Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis.Am J Surg. 1993; 166: 331-335
- Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?.Surgery. 1998; 124 ([discussion: 964-6]): 958-964
- Extent of surgery affects survival for papillary thyroid cancer.Ann Surg. 2007; 246 ([discussion: 381-4]): 375-381
- Tuttle. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer.Thyroid. 2009; 19: 1167-1214
- Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer.Head Neck. 2011; 33: 645-649
- Surgery for papillary thyroid carcinoma: is lobectomy enough?.Arch Otolaryngol Head Neck Surg. 2010; 136: 1055-1061
- Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.Surgery. 2012; 151: 571-579
- Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.Ann Surg. 2014; 260 ([discussion: 605-7]): 601-605
- Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.J Clin Endocrinol Metab. 2015; 100: 115-121
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.Thyroid : official J Am Thyroid Assoc. 2016; 26: 1-133
- BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.Medicine (Baltimore). 2012; 91: 274-286
- Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.Jama. 2013; 309: 1493-1501
- BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis.Thyroid. 2016; 26: 248-255
- Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.Surgery. 2015; 157: 119-125
- TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.J Clin Endocrinol Metab. 2014; 99: E754-E765
- BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.J Clin Oncol. 2014; 32: 2718-2726
- Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.N Engl J Med. 2012; 367: 705-715
- Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.Thyroid. 2015; 25: 1217-1223
- Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.JAMA Oncol. 2021; 7: 70-77
- An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid.Thyroid. 2003; 13: 381-387
- An observational trial for papillary thyroid microcarcinoma in Japanese patients.World J Surg. 2010; 34: 28-35
- A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.Thyroid. 2016; 26: 144-149
- Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival.World J Surg. 2016; 40: 551-561
- Financial burden and quality of life among thyroid cancer survivors.Surgery. 2020; 167: 631-637
- A Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer.Thyroid. 2022; https://doi.org/10.1089/thy.2021.0485
- Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision.Cancer. 1970; 26: 1061-1064
- Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.Surgery. 2003; 134: 946-954
- A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.Surgery. 2011; 150: 1048-1057
- Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence.Ann Surg Oncol. 2018; 25: 2526-2534
- A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer.Ann Surg Oncol. 2013; 20: 3477-3483
- Thyroid-differentiated and anaplastic carcinoma (Chapter 73).Springer International Publishing, 2017
- The impact of nodal status on outcome in older patients with papillary thyroid cancer.Surgery. 2014; 156: 137-146
- Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit.Surgery. 2010; 148: 398-403
- The Benefits and Risks of Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma: Prospective Cohort Study.Int J Endocrinol. 2015; 2015: 571480
- Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.J Clin Endocrinol Metab. 2015; 100: 1316-1324
- Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma.Eur Arch Otorhinolaryngol. 2020; 277: 569-576
- A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer.Ann Surg. 2020; 272: 496-503
- A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma.Surgery. 2022; 171: 182-189
- Prophylactic Central Neck Lymph Node Dissection in Low-Risk Thyroid Carcinoma Patients Does not Decrease the Incidence of Locoregional Recurrence: A Meta-Analysis of Randomized Trials.Ann Surg. 2022; https://doi.org/10.1097/SLA.0000000000005388
- Lobectomy Is Feasible for 1-4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence.Thyroid. 2019; 29: 64-70
- The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.JAMA Surg. 2016; 151: 959-968
- Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model.Arch Surg. 2006; 141 ([discussion: 782]): 777-782
- Use of Preoperative Imaging in Primary Hyperparathyroidism.J Clin Endocrinol Metab. 2021; 106: e328-e337
- A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism.Ann Surg Oncol. 2012; 19: 577-583
- Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT.AJNR Am J Neuroradiol. 2019; 40: 142-149
- Four-dimensional computed tomography (4D-CT) for preoperative parathyroid localization: A good study but are we using it?.Am J Surg. 2022; 223: 694-698
- Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost?.J Am Coll Surg. 2012; 214 ([discussion: 637-9]): 629-637
- Preoperative localization strategies for primary hyperparathyroidism: an economic analysis.Ann Surg Oncol. 2012; 19: 4202-4209
- Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism.Surgery. 2011; 150: 1286-1294
- Superior sensitivity of (18)F-fluorocholine: PET localization in primary hyperparathyroidism.Surgery. 2022; 171: 47-54
- (18)F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism.Diagnostics (Basel). 2021; 11
- Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients.Arch Surg May. 2006; 141 ([discussion: 487-8]): 483-487
- Focused parathyroidectomy without intraoperative parathyroid hormone measurement in primary hyperparathyroidism: Still a valid approach?.Surgery. 2021; 170: 1383-1388
- A novel optical approach to intraoperative detection of parathyroid glands.Surgery. 2013; 154 ([discussion: 1377]): 1371-1377
- Establishing the clinical utility of autofluorescence spectroscopy for parathyroid detection.Surgery. 2016; 159: 193-202
- Development of an algorithm for intraoperative autofluorescence assessment of parathyroid glands in primary hyperparathyroidism using artificial intelligence.Surgery. 2021; 170: 454-461
- Intraoperative Parathyroid Autofluorescence Detection in Patients with Primary Hyperparathyroidism.Ann Surg Oncol. 2019; 26: 1142-1148
- Near-Infrared Autofluorescence Imaging May Reduce Temporary Hypoparathyroidism in Patients Undergoing Total Thyroidectomy and Central Neck Dissection.Thyroid. 2021; 31: 1400-1408
- Parathyroid Carcinoma.Front Horm Res. 2019; 51: 63-76
- Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma.J Am Coll Surg. 2017; https://doi.org/10.1016/j.jamcollsurg.2017.01.060
- Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center.Ann Surg Oncol. 2019; 26: 3593-3599https://doi.org/10.1245/s10434-019-07451-3
- Is central lymph node dissection necessary for parathyroid carcinoma?.Surgery. 2014; 156 (; discussion 1341): 1336-1341https://doi.org/10.1016/j.surg.2014.08.005
- Parathyroid carcinoma.Best Pract Res Clin Endocrinol Metab. 2018; 32: 877-889https://doi.org/10.1016/j.beem.2018.11.002
- Genetic profiling as a clinical tool in advanced parathyroid carcinoma.J Cancer Res Clin Oncol. 2019; 145: 1977-1986https://doi.org/10.1007/s00432-019-02945-9
- Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.Oncologist. 2019; 24: 791-797
- Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.Surg Nov. 2018; 164: 960-964
- Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab.BMJ Case Rep. 2020; : 13https://doi.org/10.1136/bcr-2020-235293
- Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.Front Endocrinol (Lausanne). 2021; 12: 643328
- Laparoscopic adrenalectomy: the optimal surgical approach.J Laparoendosc Adv Surg Tech A. 2001; 11: 409-413https://doi.org/10.1089/10926420152761941
- Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program.J Am Coll Surg. 2008; 206 ([discussion: 959-61]): 953-959
- Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project.J Surg Res. 2013; 184: 216-220
- Adrenal metastectomy is safe in selected patients.World J Surg. 2014; 38: 1336-1342
- The Posterior Adiposity Index: A Quantitative Selection Tool for Adrenalectomy Approach.J Surg Res. 2019; 233: 26-31
- Lateral Transperitoneal Adrenalectomy Versus Posterior Retroperitoneoscopic Adrenalectomy for Benign Adrenal Gland Disease: Randomized Controlled Trial at a Single Tertiary Medical Center.Ann Surg. 2019; 269: 842-848
- Randomized clinical trial of posterior retroperitoneoscopic adrenalectomy versus lateral transperitoneal laparoscopic adrenalectomy with a 5-year follow-up.Ann Surg Nov. 2014; 260 (; discussion 747-8): 740-747
- Laparoscopic adrenalectomy: lateral transperitoneal versus posterior retroperitoneal approach - prospective randomized trial.Wideochir Inne Tech Maloinwazyjne. 2019; 14: 160-169
- Surgical outcomes of a randomized controlled trial compared robotic versus laparoscopic adrenalectomy for pheochromocytoma.Eur J Surg Oncol. 2020; 46: 1843-1847
- Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.Ann Surg Oncol. 2016; 23: 134-141
- Implications of Conversion during Attempted Minimally Invasive Adrenalectomy for Adrenocortical Carcinoma.Ann Surg Oncol. 2021; 28: 492-501
- Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma.J Am Coll Surg. 2016; 223: 485-492
- Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.Ann Surg Oncol. 2010; 17: 263-270
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.Eur J Endocrinol. 2018; 179: G1-G46
- Adrenalectomy for Secondary Malignancy: Patients, Outcomes, and Indications.Ann Surg. 2021; 274: 1073-1080
- Melanoma adrenal metastasis: natural history and surgical management.Am J Surg Mar. 2008; 195 ([discussion: 368-9]): 363-368
- Adrenalectomy improves outcomes of selected patients with metastatic carcinoma.World J Surg. 2012; 36: 1400-1405
- Outcome and prognosis after adrenal metastasectomy: nationwide study.BJS Open. 2022; : 6https://doi.org/10.1093/bjsopen/zrac047
- Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease.Ann Surg Aug. 2019; 270: 373-377
- The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab. 2016; 101: 1889-1916
- Resistant hypertension and aldosterone: an update.Can J Cardiol. 2012; 28: 318-325
- Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.Lancet Diabetes Endocrinol. 2016; 4: 739-746
- Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism.J Clin Endocrinol Metab. 2014; 99: 2712-2719
- Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy.Medicine (Baltimore). 2016; 95: e4986
- Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism.Clin Endocrinol (Oxf). 2018; 88: 645-651
- Preoperative selective vs non-selective α-blockade in PPGL patients undergoing adrenalectomy.Endocr Connect. 2017; 6: 830-838
- Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.J Clin Endocrinol Metab. 2020; 105: 2381-2391
- Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching.Anesth Analg. 2021; 132: 140-149
- Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas.Surgery. 2012; 152: 1027-1036
- Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma.Surgery. 2014; 156 ([discussion: 1417-8]): 1410-1417
- Perioperative α-receptor blockade in phaeochromocytoma surgery: an observational case series.Br J Anaesth Feb. 2017; 118: 182-189
- Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.Ann Surg. 2018; 268: 172-178
- The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.Pancreas. 2021; 50: 469-493
- Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.Clin Endocrinol (Oxf). 2014; 81: 642-651
- Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.J Nucl Med. 2019; 60: 623-630
- Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.ESMO Open. 2021; 6: 100171
- Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas.Cancers (Basel). 2020; : 12https://doi.org/10.3390/cancers12082307
- SDHB mutation carriers with malignant pheochromocytoma respond better to CVD.Endocr Relat Cancer. 2017; 24: L51-L55
- SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.Int J Cancer. 2014; 135: 2711-2720
- Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.J Clin Endocrinol Metab. 2012; 97: 4040-4050
- Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Cancer Cell. 2017; 31: 181-193
- Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.JAMA Netw Open. 2019; 2: e198898
- Long-term outcomes of surgical treatment for hereditary pheochromocytoma.J Am Coll Surg. 2013; 216: 280-289
- Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.J Clin Endocrinol Metab. 2000; 85: 1440-1448
- Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study.Ann Intern Med. 2022; 175: 325-334
- The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.J Clin Endocrinol Metab. 2020; 105: 1469-1477
- Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome.Surgery. 2012; 152: 991-997
- Adrenal incidentalomas and subclinical Cushing syndrome: indications to surgery and results in a series of 26 laparoscopic adrenalectomies.Ann Ital Chir. 2015; 86: 406-412
- Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study.Ann Surg. 2009; 249: 388-391
- The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH).World J Surg. 2008; 32: 882-889
- Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia.J Clin Endocrinol Metab. 2015; 100: 4417-4424
- The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias.World J Surg. 2013; 37: 1626-1632
- Long-Term Outcome of Primary Bilateral Macronodular Adrenocortical Hyperplasia After Unilateral Adrenalectomy.J Clin Endocrinol Metab. 2019; 104: 2985-2993
- Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease.Int J Clin Exp Med. 2015; 8: 19311-19317
- Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion.Surgery. 2021; 169: 150-154
- Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature.J Clin Endocrinol Metab. 2014; 99: 2637-2645
- Selective Glucocorticoid Replacement Following Unilateral Adrenalectomy for Hypercortisolism and Primary Aldosteronism.J Clin Endocrinol Metab. 2022; 107: e538-e547
Article info
Publication history
Published online: November 03, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
